Anonymous Pharmaceutical API Producer

A Spanish manufacturer of active pharmaceutical ingredients (APIs) faced mounting risk from an aging distributed control system (DCS) that could no longer be adequately supported. The facility managed approximately 1,000 batch formulations — the codified production recipes central to regulated pharmaceutical manufacturing — and needed to migrate all of them to FactoryTalk Batch 13. In a GMP environment, every formulation change typically requires individual validation, meaning a manual approach was projected to take four months and force a costly summer production shutdown. For an API producer, halting production during peak period carries significant revenue and supply-chain consequences.

Rockwell Automation implemented FactoryTalk Batch 13 with automated batch formulation migration capabilities, eliminating the need to validate each of the 1,000 recipes individually. The platform's migration tooling transferred formulations in bulk from the legacy DCS, preserving procedural logic while conforming to the new system's architecture. To satisfy 21 CFR Part 11 requirements — mandatory for electronic records and signatures in FDA-regulated pharmaceutical environments — FactoryTalk AssetCentre was deployed alongside the batch system to maintain a secure, tamper-evident audit trail. The updated operator interface was designed for intuitive use, reducing the change-management burden during cutover and allowing production staff to adapt without extensive formal retraining.

The full migration of 1,000 batch formulations was completed in three weeks, compared to the four-month estimate for a manual validation approach — roughly an 80% reduction in project duration. Critically, the accelerated timeline eliminated the planned summer production halt, preserving uninterrupted API supply. Key outcomes included:

• 1,000 formulations migrated without one-by-one manual validation
• Production continuity maintained through a period that would otherwise have required a costly shutdown
• Operators adapted to the new interface without requiring extensive retraining, indicating a well-managed transition
• 21 CFR Part 11 audit trail compliance established from day one of go-live

• Automated migration tooling in modern batch management systems can collapse multi-month pharmaceutical system upgrade timelines to weeks — evaluate vendor migration capabilities before committing to a manual validation plan.
• In regulated environments, 21 CFR Part 11 audit trail readiness must be scoped into the system replacement from the outset, not retrofitted after go-live.
• Scheduling legacy DCS replacements around production calendars is high-stakes; platforms that reduce cutover time directly reduce the window of business risk.
• Operator interface design is a change-management variable — systems that minimize retraining protect productivity during transitions where attention is already divided.